EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Digital Gait Measures Capture 1‐Year Progression in Early‐Stage Spinocerebellar Ataxia Type 2

Jens Seemann, Lina Daghsen, Matthieu Cazier, Jean-Charles Lamy, Marie-Laure Welter iD, Martin A Giese, Matthis Synofzik iD, Alexandra Durr, Winfried Ilg iD, Giulia Coarelli iD

Movement Disorders · 2024-05 · 39 (5) · 788-797

DOI: 10.1002/mds.29757 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Movement Disorders, online erschienen am 28.02.2024. Verfasst von Jens Seemann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section Computational Sensomotorics, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Disease Progression, Spinocerebellar Ataxias. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biogen, Institut National de la Santé et de la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With disease‐modifying drugs in reach for cerebellar ataxias, fine‐grained digital health measures are highly warranted to complement clinical and patient‐reported outcome measures in upcoming treatment trials and treatment monitoring. These measures need to demonstrate sensitivity to capture change, in particular in the early stages of the disease.

Objective

Our aim is to unravel gait measures sensitive to longitudinal change in the—particularly trial‐relevant—early stage of spinocerebellar ataxia type 2 (SCA2).

Methods

We performed a multicenter longitudinal study with combined cross‐sectional and 1‐year interval longitudinal analysis in early‐stage SCA2 participants (n = 23, including nine pre‐ataxic expansion carriers; median, ATXN2 CAG repeat expansion 38 ± 2; median, Scale for the Assessment and Rating of Ataxia [SARA] score 4.8 ± 4.3). Gait was assessed using three wearable motion sensors during a 2‐minute walk, with analyses focused on gait measures of spatio‐temporal variability that have shown sensitivity to ataxia severity (eg, lateral step deviation).

Results

We found significant changes for gait measures between baseline and 1‐year follow‐up with large effect sizes (lateral step deviation P = 0.0001, effect size r prb = 0.78), whereas the SARA score showed no change ( P = 0.67). Sample size estimation indicates a required cohort size of n = 43 to detect a 50% reduction in natural progression. Test–retest reliability and minimal detectable change analysis confirm the accuracy of detecting 50% of the identified 1‐year change.

Conclusions

Gait measures assessed by wearable sensors can capture natural progression in early‐stage SCA2 within just 1 year—in contrast to a clinical ataxia outcome. Lateral step deviation represents a promising outcome measure for upcoming multicenter interventional trials, particularly in the early stages of cerebellar ataxia. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease ProgressionSpinocerebellar AtaxiasHumansMaleFemaleAdultMiddle AgedLongitudinal StudiesCross-Sectional StudiesGaitGait Disorders, NeurologicAtaxin-2

Stichwörter der Autor:innen

SCA2gaitlongitudinal analysismotor performance measurespinocerebellar ataxia

Substanzen

Ataxin-2

Autor:innen und Institutionen

  • Section Computational Sensomotorics, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Centre for Integrative Neuroscience (CIN), Tübingen, Germany.
  • Sorbonne Université, Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, Paris, France.
  • Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.

ORCID-Profile: Marie-Laure Welter, Matthis Synofzik, Winfried Ilg, Giulia Coarelli

Förderung

  • Biogen
  • Institut National de la Santé et de la Recherche Médicale

Zitieren

APA

Seemann, J., Daghsen, L., Cazier, M., Lamy, J. C., Welter, M. L., Giese, M. A., Synofzik, M., Durr, A., Ilg, W., & Coarelli, G. (2024). Digital Gait Measures Capture 1‐Year Progression in Early‐Stage Spinocerebellar Ataxia Type 2. Movement Disorders, 39(5), 788-797. https://doi.org/10.1002/mds.29757

Vancouver

Seemann J, Daghsen L, Cazier M, Lamy JC, Welter ML, Giese MA, et al. Digital Gait Measures Capture 1‐Year Progression in Early‐Stage Spinocerebellar Ataxia Type 2. Movement Disorders. 2024;39(5):788-797. doi:10.1002/mds.29757

BibTeX
@article{Seemann2024,
  author = {Seemann, Jens and Daghsen, Lina and Cazier, Matthieu and Lamy, Jean-Charles and Welter, Marie-Laure and Giese, Martin A and Synofzik, Matthis and Durr, Alexandra and Ilg, Winfried and Coarelli, Giulia},
  title = {Digital Gait Measures Capture 1‐Year Progression in Early‐Stage Spinocerebellar Ataxia Type 2},
  journal = {Movement Disorders},
  year = {2024},
  volume = {39},
  number = {5},
  pages = {788--797},
  doi = {10.1002/mds.29757}
}
Kostenlos starten →